Phosphoproteomic signatures for early detection and stratification of AML

Scott Davis

Exposures from Chernobyl

Leukaemia

Pediatric oncology or childhood cancer Radiation Oncology

Carl E Allen

Redefining Langerhans Cell Histiocytosis as a Myeloid Dysplasia and Identifying Biomarkers for Early Detection and Risk Assessment

Leukaemia

Peter Blumberg

Molecular Mechanism of Action of Phorbol Ester

Prostate Melanoma of skin Leukaemia All cancers but non-melanoma skin cancer

Scott W Lowe

The impact of chromosome 17p lesions on leukemogeneis and therapy response

Leukaemia

Hematology and hematologic malignancies Pathology

Investigator from BioInvent (Sweden)

Clinical validation of the CD32b biomarker on the European market

Leukaemia

Pathology

Investigator from Ludwig Boltzmann Gesellschaft (LBG)

Common Oncogenic Mechanisms in Multi-Partner Translocation Families in Acute Myeloid Leukemia

Leukaemia

Qing Lan

A Hospital-based Case-control Study of Lymphoma in Asia (AsiaLymph)

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Monica J Justice

The Pluripotency Regulator Prdm14 Initiates Cancer by Epigenetic Mechanisms

Leukaemia

Hematology and hematologic malignancies Pathology

Amy Paguirigan

Connecting Single Cell Heterogeneity to Clinical Descriptors of Clonal Evolution in Acute Myeloid Leukemia

Leukaemia